Tag: Invokana
-
Four Distinct Diabetes Drugs MDL Cases: Byetta / Januvia / Victoza; Onglyza / Kombiglyze; Invokana; Farxiga
Current Number Of Drug Injury Lawsuits Filed In Each Of These Ongoing Federal Court MDL Cases: February 2018 JPML Report (Posted by Tom Lamb at DrugInjuryWatch.com) At the present time there are…
-
Jardiance – Amputations Drug Safety Issue Remains Uncertain Due To Admitted “inherent limitations of… post hoc analyses”
Jardiance Seemingly Not Associated With Amputations Per Reexamination Of Drug Company Funded EMPA-REG OUTCOME® Trial Data (Posted by Tom Lamb at DrugInjuryWatch.com) In April 2016 the European Medicines Agency (EMA) warned that…
-
Invokana – Amputations Of Lower Limbs: A Drug Side Effect Which Needs Further Explanation As Regards “How” And “Why”
Future Clinical Trials And Investigations Need To Clarify Whether This Amputation Drug Injury Could Be A Class Effect Of All SGLT2 Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) During this year we…
-
A “Dear Doctor” Letter For Invokana Amputations Side Effect Was Sent September 2017 By Janssen In Canada
In US There Was A “Black-Box Warning” Added On Revised Drug Label Issued In July 2017 But Without Any Such Letter, It Seems (Posted by Tom Lamb at DrugInjuryWatch.com) The “FDA Drug…
-
Analysis Of FDA Adverse Event Reports Describes Extent And Nature of Invokamet / Invokana – Amputation Side Effect
This New Medical Research Was Published Just Before “Black-Box Warning” About Lower Limb Amputations Added To Drug Labels (Posted by Tom Lamb at DrugInjuryWatch.com) In the final week of July 2017, the…
-
Invokana – Amputation Side Effect Gets “Black-Box Warning” On Revised Drug Label Issued In July 2017
This Label Change Was Previewed In A May 2017 FDA Drug Safety Communication About Increased Risk Of Leg And Foot Amputations (Posted by Tom Lamb at DrugInjuryWatch.com) A June 2017 article, “Invokana…
-
Jardiance, Invokana, Farxiga, And The Other SGLT2 Inhibitors Might Double The Risk Of Diabetic Ketoacidosis (DKA)
Study Compared Newly Initiated Use Of SGLT2 Inhibitor To New Initiation Of Another Class Of Diabetes Drugs To Assess The DKA Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) All of these…
-
Federal Court Invokana MDL: Judge Martinotti Is Presiding Over These Drug Injury Lawsuits In New Jersey
A December 2016 Judicial Panel for Multidistrict Litigation (JPML) Order Consolidated All Invokana And Invokamet Cases (Posted by Tom Lamb at DrugInjuryWatch.com) In September 2016, pursuant to 28 U.S.C. § 1407, a…
-
Diabetes Medicine Invokana Gets New Warning About Lower Limb Amputation Added To Drug Package Insert In Canada
This December 2016 Label Change Mandated By Health Canada, However, Does Not Apply To Jardiance, Farxiga, And The Rest Of SGLT2 Inhibitors Class Of Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE:…
-
FDA Mandates Label Change Warning About Fatal Cases Of Ketoacidosis For All Diabetes Drugs Known As Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors
This Class Of (Heavily Advertised) Drugs Includes Farxiga, Invokana, And Jardiance, Which Also Are Linked To Kidney Failure And Heart Attacks Or Myocardial Infarction (Posted by Tom Lamb at DrugInjuryWatch.com) In an…